FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Moellering

Research Profile

Chemicals & Drugs

Procedures

Microbial Sensitivity Tests

Physiology

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Wen-Hua Chen; Robert C Moellering; Christine Wennersten; Steven L Regen
Towards squalamine mimics: synthesis and antibacterial activities of head-to-tail dimeric sterol-polyamine conjugates.
David R Cameron; George M Eliopoulos; Benjamin P Howden; Xenia Kostoulias; Robert C Moellering; Doyle V Ward; Anton Y Peleg
Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus.
Robert C Moellering; Mary Jane Ferraro
Introduction: Solving the clinical problem of vancomycin resistance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Moellering (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wen-Hua Chen; Robert C Moellering; Christine Wennersten; Steven L Regen
Towards squalamine mimics: synthesis and antibacterial activities of head-to-tail dimeric sterol-polyamine conjugates.
Chemistry & biodiversity 2013;10(3):385-93.
2012: David R Cameron; George M Eliopoulos; Benjamin P Howden; Xenia Kostoulias; Robert C Moellering; Doyle V Ward; Anton Y Peleg
Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus.
The Journal of infectious diseases 2012;205(11):1677-87.
2012: Robert C Moellering; Mary Jane Ferraro
Introduction: Solving the clinical problem of vancomycin resistance.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54 Suppl 3():S201-2.
2011: Robert C Moellering; G Ralph Corey; M Lindsay Grayson
Introduction: fusidic acid enters the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52 Suppl 7():S467-8.
2011: Robert C Moellering; Gerald F Abbott; Mary Jane Ferraro
Case records of the Massachusetts General Hospital. Case 2-2011. A 30-year-old woman with shock after treatment of a furuncle.
The New England journal of medicine 2011;364(3):266-75.
2011: Robert C Moellering
Discovering new antimicrobial agents.
International journal of antimicrobial agents 2011;37(1):2-9.
2010: Robert C Moellering
NDM-1--a cause for worldwide concern.
The New England journal of medicine 2010;363(25):2377-9.
2010: Robert C Moellering
The problem of complicated skin and skin structure infections: the need for new agents.
The Journal of antimicrobial chemotherapy 2010;65 Suppl 4():iv3-8.
2010: Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2010;54(2):773-7.
2010: Robert C Moellering; Anna A Mattson-DiCecca; Eileen E Reynolds
Update: A 39-year-old man with a skin infection.
JAMA : the journal of the American Medical Association 2010;303(1):64.
2010: Glenn F Webb; Erika M C D'Agata; Mary Ann Horn; Robert C Moellering; Shigui Ruan
Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals.
Journal of biological dynamics 2010;4(1):115-29.
2009: Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; William A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
Pharmacotherapy 2009;29(11):1275-9.
2009: Satish K Pillai; Christine Wennersten; Lata Venkataraman; George Miltiades Eliopoulos; Robert C Moellering; Adolf W Karchmer
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(8):1169-74.
2009: Robert C Moellering
What is inadequate antibacterial therapy?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(7):1006-8.
2009: Robert C Moellering
New treatments for multiply drug-resistant Gram-positive bacteria.
The Journal of infection 2009;59 Suppl 1():S1-3.
2009: Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(3):325-7.
2009: Anton Y Peleg; Sebastian Jara; Divya Monga; George Miltiades Eliopoulos; Robert C Moellering; Eleftherios Mylonakis
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
Antimicrobial agents and chemotherapy 2009;53(6):2605-9.
2009: Christoph Naber; Larry M Baddour; Evangelos J Giamarellos-Bourboulis; Ian M Gould; Mathias Herrmann; Bruno Hoen; Adolf W Karchmer; Yoshio Kobayashi; Roman S Kozlov; Daniel Lew; José M Miró; Robert C Moellering; Philippe Moreillon; Georg Peters; Ethan Rubinstein; Harald Seifert; G Ralph Corey
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48 Suppl 4():S260-70.
2009: A Y Peleg; Y Tilahun; M J Fiandaca; Erika M C D'Agata; Lata Venkataraman; Robert C Moellering; George Miltiades Eliopoulos
Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa.
Journal of clinical microbiology 2009;47(3):830-2.
2009: Anton Y Peleg; Divya Monga; Satish Pillai; Eleftherios Mylonakis; Robert C Moellering; George Miltiades Eliopoulos
Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.
The Journal of infectious diseases 2009;199(4):532-6.
2009: Erika M C D'Agata; Glenn F Webb; Mary Ann Horn; Robert C Moellering; Shigui Ruan
Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):274-84.
2008: Jean-Baptiste Michel; Pamela J Yeh; Remy Chait; Robert C Moellering; Roy Kishony
Drug interactions modulate the potential for evolution of resistance.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(39):14918-23.
2008: Anton Y Peleg; Emmanouil Tampakakis; Beth Burgwyn Fuchs; George Miltiades Eliopoulos; Robert C Moellering; Eleftherios Mylonakis
Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(38):14585-90.
2008: Henry F Chambers; Robert C Moellering; Paul Kamitsuka
Clinical decisions. Management of skin and soft-tissue infection.
The New England journal of medicine 2008;359(10):1063-7.
2008: Zukile Gqada; Ben Marais; Elizabeth Wasserman; Colleen Bamford; Heidi Orth; George Sakoulas; Warren E Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George Miltiades Eliopoulos
Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Journal of clinical microbiology 2008;46(7):2471; author reply 2471-2.
2008: George Sakoulas; Robert C Moellering
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46 Suppl 5():S360-7.
2008: Robert C Moellering
Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(7):1032-7.
2008: Robert C Moellering
A 39-year-old man with a skin infection.
JAMA : the journal of the American Medical Association 2008;299(1):79-87.
2008: George Sakoulas; Warren E Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George Miltiades Eliopoulos
Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Journal of clinical microbiology 2008;46(1):220-4.
2007: Robert C Moellering; John Graybill; John E McGowan; Lawrence Corey
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
American journal of infection control 2007;35(9):S1-23; quiz S24-6.
2007: Athanassios Tsakris; Satish K Pillai; Howard S Gold; Claudie Thauvin-Eliopoulos; Lata Venkataraman; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2007;60(3):649-51.
2007: Robert C Moellering; John Graybill; John E McGowan; Lawrence Corey
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
The American journal of medicine 2007;120(7):S4-25; quiz S26-8.
2007: Satish K Pillai; Howard S Gold; George Sakoulas; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Antimicrobial agents and chemotherapy 2007;51(6):2223-5.
2007: Shonna M McBride; Vincent Fischetti; Donald J Leblanc; Robert C Moellering; Michael S Gilmore
Genetic diversity among Enterococcus faecalis.
PloS one 2007;2(7):e582.
2006: Wen-Hua Chen; Xue-Bin Shao; Robert C Moellering; Christine Wennersten; Steven L Regen
A bioconjugate approach toward squalamine mimics: Insight into the mechanism of biological action.
Bioconjugate chemistry 2006;17(6):1582-91.
2006: George Sakoulas; Jeff Alder; Claudie Thauvin-Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
Antimicrobial agents and chemotherapy 2006;50(4):1581-5.
2006: George Sakoulas; Howard S Gold; Robert A Cohen; Lata Venkataraman; Robert C Moellering; George Miltiades Eliopoulos
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
The Journal of antimicrobial chemotherapy 2006;57(4):699-704.
2006: George Sakoulas; Robert C Moellering; George Miltiades Eliopoulos
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42 Suppl 1():S40-50.
2006: Robert C Moellering
Vancomycin: a 50-year reassessment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42 Suppl 1():S3-4.
2005: Robert C Moellering
The management of infections due to drug-resistant gram-positive bacteria.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(12):777-9.
2005: George Miltiades Eliopoulos; Mary Jane Ferraro; Christine Wennersten; Robert C Moellering
In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria.
Antimicrobial agents and chemotherapy 2005;49(7):3034-9.
2005: George Sakoulas; George Miltiades Eliopoulos; Vance G Fowler; Robert C Moellering; Richard novick; Natalie Lucindo; Michael Yeaman; Arnold S Bayer
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
Antimicrobial agents and chemotherapy 2005;49(7):2687-92.
2004: Robert W Finberg; Robert C Moellering; Francis P Tally; William A Craig; George A Pankey; E Patchen Dellinger; Michael A West; Manjari Joshi; Peter K Linden; Ken V Rolston; John C Rotschafer; Michael J Rybak
The importance of bactericidal drugs: future directions in infectious disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(9):1314-20.
2004: Venkata G Meka; Howard S Gold; Amy Cooke; Lata Venkataraman; George Miltiades Eliopoulos; Robert C Moellering; Stephen G Jenkins
Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2004;54(4):818-20.
2004: Satish K Pillai; George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Barbara E Murray; Roger T Inouye
Effects of glucose on fsr-mediated biofilm formation in Enterococcus faecalis.
The Journal of infectious diseases 2004;190(5):967-70.
2004: Venkata G Meka; Satish K Pillai; George Sakoulas; Christine Wennersten; Lata Venkataraman; Paola C DeGirolami; George Miltiades Eliopoulos; Robert C Moellering; Howard S Gold
Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
The Journal of infectious diseases 2004;190(2):311-7.
2004: Pamela A Moise-Broder; George Sakoulas; George Miltiades Eliopoulos; Jerome J Schentag; Alan Forrest; Robert C Moellering
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(12):1700-5.
2004: George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George Miltiades Eliopoulos
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Journal of clinical microbiology 2004;42(6):2398-402.
2003: George Sakoulas; Howard S Gold; Lata Venkataraman; Robert C Moellering; Mary Jane Ferraro; George Miltiades Eliopoulos
Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.
The Journal of antimicrobial chemotherapy 2003;51(4):1039-41.
2003: George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Richard novick; Lata Venkataraman; Christine Wennersten; Paola C DeGirolami; Mitchell J Schwaber; Howard S Gold
Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?
The Journal of infectious diseases 2003;187(6):929-38.
2003: Robert C Moellering
New approaches to developing antimicrobials for resistant bacteria.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2003;9(1):8-11.
2003: Robert C Moellering
Linezolid: the first oxazolidinone antimicrobial.
Annals of internal medicine 2003;138(2):135-42.
2002: Satish K Pillai; George Sakoulas; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Mary Jane Ferraro; Howard S Gold
Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
The Journal of infectious diseases 2002;186(11):1603-7.
2002: George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
In vitro activity of the new oxazolidinone AZD2563 against Enterococci.
Antimicrobial agents and chemotherapy 2002;46(10):3273-5.
2002: Robert C Moellering; William Craig; Michael B Edmond; David J Farrell; Mary Jane Ferraro; Thomas M File; Jerome Klein; John Lonks; Joshua P Metlay; Daniel Sahm; George H Talbot
Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae.
Journal of chemotherapy (Florence, Italy) 2002;14 Suppl 3():42-56.
2002: Satish K Pillai; George Sakoulas; Howard S Gold; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Roger T Inouye
Prevalence of the fsr locus in Enterococcus faecalis infections.
Journal of clinical microbiology 2002;40(7):2651-2.
2002: George Sakoulas; George Miltiades Eliopoulos; Robert C Moellering; Christine Wennersten; Lata Venkataraman; Richard novick; Howard S Gold
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Antimicrobial agents and chemotherapy 2002;46(5):1492-502.
2002: Lindsey R Baden; I A Critchley; D F Sahm; W So; M Gedde; S Porter; Robert C Moellering; George Miltiades Eliopoulos
Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin.
Journal of clinical microbiology 2002;40(4):1160-3.
2001: Peter K Linden; Robert C Moellering; C A Wood; Susan J Rehm; J Flaherty; F Bompart; George H Talbot
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1816-23.
2001: Lindsey R Baden; W Thiemke; A Skolnik; R Chambers; J Strymish; Howard S Gold; Robert C Moellering; George Miltiades Eliopoulos
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance".
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(10):1654-60.
2001: S Tsiodras; Howard S Gold; George Sakoulas; George Miltiades Eliopoulos; Christine Wennersten; Lata Venkataraman; Robert C Moellering; Mary Jane Ferraro
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
Lancet 2001;358(9277):207-8.
2001: C Torres-Viera; S Tsiodras; Howard S Gold; Eoin P G Coakley; Christine Wennersten; George Miltiades Eliopoulos; Robert C Moellering; Roger T Inouye
Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer.
Antimicrobial agents and chemotherapy 2001;45(3):973-5.
2000: S Tsiodras; Howard S Gold; Eoin P G Coakley; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
Diversity of domain V of 23S rRNA gene sequence in different Enterococcus species.
Journal of clinical microbiology 2000;38(11):3991-3.
2000: A M Queenan; C Torres-Viera; Howard S Gold; Yehuda Carmeli; George Miltiades Eliopoulos; Robert C Moellering; J P Quinn; Janet Hindler; A A Medeiros; Karen Bush
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.
Antimicrobial agents and chemotherapy 2000;44(11):3035-9.
1999: T Schülin; Claudie Thauvin-Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Antimicrobial agents and chemotherapy 1999;43(12):2873-6.
1999: Belinda Ostrowsky; N C Clark; Claudie Thauvin-Eliopoulos; Lata Venkataraman; Matthew H Samore; Fred C Tenover; George Miltiades Eliopoulos; Robert C Moellering; Howard S Gold
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology.
The Journal of infectious diseases 1999;180(4):1177-85.
1999: Robert C Moellering
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections.
The Journal of antimicrobial chemotherapy 1999;44 Suppl A():25-30.
1999: Robert C Moellering; Peter K Linden; J Reinhardt; E A Blumberg; F Bompart; George H Talbot
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
The Journal of antimicrobial chemotherapy 1999;44(2):251-61.
1998: T Schülin; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
The Journal of antimicrobial chemotherapy 1998;42(3):297-301.
1998: Robert C Moellering
Antibiotic resistance: lessons for the future.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27 Suppl 1():S135-40; discussion S141-2.
1998: Robert C Moellering
Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. Introduction.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(6):403-4.
1998: T Schülin; Christine Wennersten; Mary Jane Ferraro; Robert C Moellering; George Miltiades Eliopoulos
Susceptibilities of Legionella spp. to newer antimicrobials in vitro.
Antimicrobial agents and chemotherapy 1998;42(6):1520-3.
1998: Robert C Moellering
The specter of glycopeptide resistance: current trends and future considerations.
The American journal of medicine 1998;104(5A):3S-6S.
1998: Robert C Moellering; P K Linden
The specter of glycopeptide resistance: current trends and future considerations. Introduction.
The American journal of medicine 1998;104(5A):1S-2S.
1998: Robert C Moellering
Vancomycin-resistant enterococci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(5):1196-9.
1998: Robert C Moellering
Problems with antimicrobial resistance in gram-positive cocci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(5):1177-8.
1998: George Miltiades Eliopoulos; Christine Wennersten; Howard S Gold; T Schülin; M Souli; MG Farris; S Cerwinka; HL Nadler; M Dowzicky; George H Talbot; Robert C Moellering
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.
Antimicrobial agents and chemotherapy 1998;42(5):1088-92.
1997: F Caron; Howard S Gold; Christine Wennersten; MG Farris; Robert C Moellering; George Miltiades Eliopoulos
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
Antimicrobial agents and chemotherapy 1997;41(12):2749-53.
1997: T Schülin; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
Antimicrobial agents and chemotherapy 1997;41(5):1196-202.
1997: Claudie Thauvin-Eliopoulos; M F Tripodi; Robert C Moellering; George Miltiades Eliopoulos
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
Antimicrobial agents and chemotherapy 1997;41(5):1053-7.
1996: George Miltiades Eliopoulos; Christine Wennersten; Howard S Gold; Robert C Moellering
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
Antimicrobial agents and chemotherapy 1996;40(7):1745-7.
1996: George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
Diagnostic microbiology and infectious disease 1996;25(1):35-41.
1995: Emilia Cercenado; S Unal; C T Eliopoulos; Lorry Rubin; H D Isenberg; Robert C Moellering; George Miltiades Eliopoulos
Characterization of vancomycin resistance in Enterococcus durans.
The Journal of antimicrobial chemotherapy 1995;36(5):821-5.
1995: G Malanoski; L Collins; C T Eliopoulos; Robert C Moellering; George Miltiades Eliopoulos
Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria.
Antimicrobial agents and chemotherapy 1995;39(4):990-5.
1995: George Miltiades Eliopoulos; Christine Wennersten; G Cole; D Chu; D Pizzuti; Robert C Moellering
In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent.
Antimicrobial agents and chemotherapy 1995;39(4):850-3.
1994: George Miltiades Eliopoulos; Christine Wennersten; G Cole; Robert C Moellering
In vitro activities of two glycylcyclines against gram-positive bacteria.
Antimicrobial agents and chemotherapy 1994;38(3):534-41.
1994: ANGELOS PEFANIS; C Thauvin-Eliopoulos; J Holden; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.
Antimicrobial agents and chemotherapy 1994;38(2):252-5.
1994: L A Collins; Christine Wennersten; M J Ferraro; Robert C Moellering; George Miltiades Eliopoulos
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.
Antimicrobial agents and chemotherapy 1994;38(1):144-6.
1993: G J Malanoski; L Collins; Christine Wennersten; Robert C Moellering; George Miltiades Eliopoulos
In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria.
Antimicrobial agents and chemotherapy 1993;37(9):2009-16.
1993: ANGELOS PEFANIS; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis.
The Journal of antimicrobial chemotherapy 1993;32(2):307-12.
1993: Howard S Gold; S Unal; Emilia Cercenado; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.
Antimicrobial agents and chemotherapy 1993;37(8):1604-9.
1993: L A Collins; George Miltiades Eliopoulos; Christine Wennersten; M J Ferraro; Robert C Moellering
In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
Antimicrobial agents and chemotherapy 1993;37(6):1364-6.
1993: L A Collins; G J Malanoski; George Miltiades Eliopoulos; Christine Wennersten; M J Ferraro; Robert C Moellering
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
Antimicrobial agents and chemotherapy 1993;37(3):598-601.
1993: ANGELOS PEFANIS; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Robert C Moellering
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Antimicrobial agents and chemotherapy 1993;37(3):507-11.
1993: George Miltiades Eliopoulos; K Klimm; C T Eliopoulos; M J Ferraro; Robert C Moellering
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.
Antimicrobial agents and chemotherapy 1993;37(2):366-70.
1993: G J Malanoski; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(2):131-3.
1993: Robert C Moellering
Meeting the challenges of beta-lactamases.
The Journal of antimicrobial chemotherapy 1993;31 Suppl A():1-8.
1992: Emilia Cercenado; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.
Antimicrobial agents and chemotherapy 1992;36(11):2526-8.
1992: Emilia Cercenado; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.
Antimicrobial agents and chemotherapy 1992;36(10):2201-3.
1992: George Miltiades Eliopoulos; C Thauvin-Eliopoulos; Robert C Moellering
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(1):58-62.
1992: Robert C Moellering; N F Jacobs
Advances in outpatient antimicrobial therapy: loracarbef.
The American journal of medicine 1992;92(6A):1S.
1992: Robert C Moellering
Emergence of Enterococcus as a significant pathogen.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(6):1173-6.
1992: Robert C Moellering
29th annual meeting of the Infectious Diseases Society of America.
The Journal of infectious diseases 1992;165(2):229-34.
1992: Louis B Rice; C T Eliopoulos; J D Yao; George Miltiades Eliopoulos; Robert C Moellering
In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model.
Diagnostic microbiology and infectious disease 1992;15(2):173-6.
1992: T L Hodges; S Zighelboim-Daum; George Miltiades Eliopoulos; Christine Wennersten; Robert C Moellering
Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.
Antimicrobial agents and chemotherapy 1992;36(1):121-5.
1991: M L Grayson; George Miltiades Eliopoulos; Christine Wennersten; Kathryn L Ruoff; P C De Girolami; M J Ferraro; Robert C Moellering
Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.
Antimicrobial agents and chemotherapy 1991;35(11):2180-4.
1991: Robert C Moellering
Introduction: revolutionary changes in the macrolide and azalide antibiotics.
The American journal of medicine 1991;91(3A):1S-4S.
1991: M L Grayson; George Miltiades Eliopoulos; Christine Wennersten; Kathryn L Ruoff; K Klimm; F L Sapico; A S Bayer; Robert C Moellering
Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance.
Antimicrobial agents and chemotherapy 1991;35(7):1408-12.
1991: Louis B Rice; J D Yao; K Klimm; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.
Antimicrobial agents and chemotherapy 1991;35(6):1243-4.
1991: Louis B Rice; George Miltiades Eliopoulos; Christine Wennersten; Donald A Goldmann; George Jacoby; Robert C Moellering
Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis.
Antimicrobial agents and chemotherapy 1991;35(2):272-6.
1990: Louis B Rice; S H Willey; Genovefa A Papanicolaou; AA Medeiros; George Miltiades Eliopoulos; Robert C Moellering; George Jacoby
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.
Antimicrobial agents and chemotherapy 1990;34(11):2193-9.
1990: T L Hodges; George Miltiades Eliopoulos; K Klimm; Robert C Moellering
In vitro activity of BAY v 3522, a new cephalosporin for oral administration.
Antimicrobial agents and chemotherapy 1990;34(9):1849-54.
1990: M L Grayson; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; J D Yao; D V DeAngelis; L Walton; J L Woolley; Robert C Moellering
Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.
Antimicrobial agents and chemotherapy 1990;34(9):1792-4.
1990: George Miltiades Eliopoulos; K Klimm; Louis B Rice; M J Ferraro; Robert C Moellering
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
Antimicrobial agents and chemotherapy 1990;34(6):1154-9.
1990: C Thauvin-Eliopoulos; Louis B Rice; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Antimicrobial agents and chemotherapy 1990;34(5):728-32.
1990: J D Yao; C Thauvin-Eliopoulos; George Miltiades Eliopoulos; Robert C Moellering
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
Antimicrobial agents and chemotherapy 1990;34(5):827-30.
1990: Robert C Moellering
The enterococci: an enigma and a continuing therapeutic challenge.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(2):73-4.
1989: George Miltiades Eliopoulos; K Klimm; M J Ferraro; George Jacoby; Robert C Moellering
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).
Diagnostic microbiology and infectious disease 1989;12(6):481-8.
1989: M L Grayson; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(10):888-9.
1989: Robert C Moellering; George Miltiades Eliopoulos; D E Sentochnik
The carbapenems: new broad spectrum beta-lactam antibiotics.
The Journal of antimicrobial chemotherapy 1989;24 Suppl A():1-7.
1989: S H Willey; R G Hindes; George Miltiades Eliopoulos; Robert C Moellering
Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.
Surgery, gynecology & obstetrics 1989;169(3):199-202.
1989: D E Sentochnik; George Miltiades Eliopoulos; M J Ferraro; Robert C Moellering
Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent.
Antimicrobial agents and chemotherapy 1989;33(8):1232-6.
1989: R G Hindes; S H Willey; George Miltiades Eliopoulos; Louis B Rice; C T Eliopoulos; B E Murray; Robert C Moellering
Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
Antimicrobial agents and chemotherapy 1989;33(7):1019-22.
1989: George Miltiades Eliopoulos; K Klimm; M J Ferraro; Robert C Moellering
In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):624-6.
1989: J D Yao; George Miltiades Eliopoulos; Robert C Moellering
In vitro activity of SK&F 104662, a new glycopeptide antibiotic.
Antimicrobial agents and chemotherapy 1989;33(6):965-7.
1989: Louis B Rice; George Miltiades Eliopoulos; Robert C Moellering
In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.
Antimicrobial agents and chemotherapy 1989;33(4):470-3.
1988: George Miltiades Eliopoulos; Christine Wennersten; S Zighelboim-Daum; E Reiszner; Donald A Goldmann; Robert C Moellering
High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.
Antimicrobial agents and chemotherapy 1988;32(10):1528-32.
1988: J S Daly; George Miltiades Eliopoulos; S Willey; Robert C Moellering
Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound.
Antimicrobial agents and chemotherapy 1988;32(9):1341-6.
1988: J S Daly; George Miltiades Eliopoulos; E Reiszner; Robert C Moellering
Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds.
The Journal of antimicrobial chemotherapy 1988;21(6):721-30.
1988: P G Spitzer; George Miltiades Eliopoulos; A W Karchmer; Robert C Moellering
Synergistic activity between vancomycin or teicoplanin and gentamicin or tobramycin against pathogenic diphtheroids.
Antimicrobial agents and chemotherapy 1988;32(4):434-7.
1987: J D Allan; George Miltiades Eliopoulos; E Reiszner; Robert C Moellering
In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents.
Antimicrobial agents and chemotherapy 1987;31(12):1997-2001.
1987: George Miltiades Eliopoulos; E Reiszner; M J Ferraro; Robert C Moellering
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
The Journal of antimicrobial chemotherapy 1987;20(5):671-5.
1987: George Miltiades Eliopoulos; Christine Wennersten; E Reiszner; Robert C Moellering
Comparative in vitro activity of CGP 31608, a new penem antibiotic.
Antimicrobial agents and chemotherapy 1987;31(8):1188-93.
1987: George Miltiades Eliopoulos; E Reiszner; Christine Wennersten; Robert C Moellering
In vitro activity of BMY-28100, a new oral cephalosporin.
Antimicrobial agents and chemotherapy 1987;31(4):653-6.
1987: P G Spitzer; George Miltiades Eliopoulos; A W Karchmer; Robert C Moellering
Comparative in vitro activity of the new cyclic lipopeptide LY146032 against Corynebacterium species.
European journal of clinical microbiology 1987;6(2):183-5.